ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,099.96
1.02%
Dow Jones
38,239.66
0.40%
US Dollar vs MXN
17.1601
0.00%
Brent Oil
88.165
0.00%
Bitcoin
63,507.08
0.15%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Axonics Inc (AXNX)

  7. Axonics Inc (AXNX) Noticias

AXNX Axonics Inc

66.69
0.15 (0.23%)
26 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Axonics Inc AXNX NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.15 0.23% 66.69 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
66.75 66.50 66.875 66.69 66.54
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
24/4/202405:30PRNUSBoston Scientific Announces Results for First Quarter 2024
22/3/202415:01BWAxonics Stockholders Approve Merger Agreement with Boston..
21/3/202415:54BWAxonics Provides Update on Inter Partes Review Proceedings
14/3/202405:00BWAxonics Receives CE Mark Approval for Fourth-Generation..
07/3/202416:24EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
29/2/202415:01BWAxonics Responds to ITC Action by Medtronic
28/2/202415:05EDGAR2Form 8-K - Current report
28/2/202415:01BWAxonics Reports Fourth Quarter and Fiscal Year 2023..
22/2/202407:00EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..
02/2/202417:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202416:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202416:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202416:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202405:30PRNUSBoston Scientific Announces Results for Fourth Quarter and..
10/1/202419:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202414:07PRNUSKuehn Law Encourages AMAM, HARP, AXNX, and CPE Investors to..
08/1/202416:19EDGAR2Form DEF 14A - Other definitive proxy statements
08/1/202416:19EDGAR2Form 8-K - Current report
08/1/202415:55PRNUSALERT: Rowley Law PLLC is Investigating Proposed Acquisition..
08/1/202410:36DJNAxonics Shares Climb 20% After Acquisition by Boston..
08/1/202407:47EDGAR2Form 8-K - Current report
08/1/202406:41DJNBoston Scientific To Acquire Axonics For About $3.7 Billion
08/1/202406:00BWAxonics Announces Definitive Agreement to be Acquired by..
28/12/202318:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/12/202315:01BWAxonics to Present at the J.P. Morgan Healthcare Conference
26/12/202312:31EDGAR2Form 144 - Report of proposed sale of securities
06/11/202311:00GLOBERevolutionizing Care: NeuroQure’s Groundbreaking Path to..
01/11/202305:00BWAxonics to Participate in November Investor Conferences
30/10/202315:06EDGAR2Form 8-K - Current report
30/10/202315:01BWAxonics Reports Third Quarter 2023 Financial Results
06/10/202319:04EDGAR2Form 3 - Initial statement of beneficial ownership of..
04/10/202315:08EDGAR2Form 8-K - Current report
03/10/202318:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202305:00BWAxonics to Report Third Quarter 2023 Financial Results on..
25/8/202305:00BWAxonics to Participate in September Investor Conferences
21/8/202316:59EDGAR2Form 144 - Report of proposed sale of securities
21/8/202316:30EDGAR2Form 8-K - Current report
21/8/202305:00BWAxonics Announces CFO Retirement and Appoints Successor
31/7/202316:23EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
27/7/202315:05EDGAR2Form 8-K - Current report
27/7/202315:01BWAxonics Reports Second Quarter 2023 Financial Results
29/6/202305:00BWAxonics to Report Second Quarter 2023 Financial Results on..
28/6/202319:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/6/202319:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/5/202315:01BWAxonics Reports First Quarter 2023 Financial Results

Su Consulta Reciente

NASDAQ
AXNX
Axonics
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados